Lorraine L. Janeczko, MPH Clinicians are using dupilumab off label to treat a wider range of allergic conditions in adults and children.The drug, marketed as Dupixent, is currently approved in the United States to treat atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyposis, eosinophilic esophagitis, and prurigo nodularis in adults. Dupilumab is also approved to...